ClearSky is heading to MEDICA 2017

ClearSky is heading to MEDICA 2017

ClearSky Medical Diagnostics is looking forward to attending and exhibiting at MEDICA 2017, the international medical trade fair. MEDICA is the world’s largest event for the medical sector – more than 128,000 international trade visitors from 70 countries attended the...
Dr Morris strengthens the ClearSky team

Dr Morris strengthens the ClearSky team

Dr Keith Morris has been appointed the Quality Assurance and Regulatory Affairs Counsel for ClearSky Medical Diagnostics. Keith has more than 20 years’ experience in the pharmaceutical, healthcare and medical industries and huge experience of regulatory and quality...
Finger tapping test and Parkinson’s

Finger tapping test and Parkinson’s

Diagnosis of Parkinson’s can be difficult to confirm by conventional assessments – relying on the judgement of a clinician observing and rating a patient’s movements, or costly brain scans. It is estimated that clinical mis-diagnosis rates of Parkinson’s may be...
ClearSky attends MDS Congress 2017

ClearSky attends MDS Congress 2017

ClearSky Medical Diagnostics headed to Vancouver at the start of June for the 21st International Congress of Parkinson’s Disease and Movement Disorders. Hosted by the International Parkinson and Movement Disorder Society (MDS), the Congress took place from 4 to...
China visit for ClearSky

China visit for ClearSky

The ClearSky Medical Diagnostics (CSMD) team recently enjoyed a successful trip to China, introducing technologies that make the diagnosis and monitoring of neurodegenerative conditions both easier and more reliable. Dr Stephen Smith (ClearSky’s Chief Scientific...
LID-Monitor gets CE Mark approval

LID-Monitor gets CE Mark approval

ClearSky’s LID-Monitor, a device for tracking movements of people with Parkinson’s over a 24-hour period, has received the CE Mark of approval. The regulatory nod clears ClearSky to start selling the LID-Monitor system, which could save the NHS up to £84 million per...